The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024.Adam Glanzman | Bloomberg | Getty PicturesModerna on Monday stated its experimental mRNA-based flu vaccine produced a stronger immune response than a presently accessible shot in a late-stage...